Search research articles
Contact Us
Filters
Showing results (41-50 of 281) with videos related to
Page
of 29
Sort By:
Molecules (Basel, Switzerland)
|
May 31, 2018
Small Universal Bacteria and Plasmid Computing Systems
Xun Wang, Pan Zheng, Tongmao Ma, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 25, 2025
Drug Development
Peng Wang, Ido Weiss, Pan Zheng, et al.
Plos One
|
October 27, 2010
Transgenic expression of P1A induced thymic tumor: a role for onco-fetal antigens in tumorigenesis
Chi-Shan Li, Chong Chen, Pan Zheng, et al.
Science (New York, N.Y.)
|
March 7, 2009
CD24 and Siglec-10 selectively repress tissue damage-induced immune responses
Guo-Yun Chen, Jie Tang, Pan Zheng, et al.
Cancer Research
|
June 18, 2002
Anti-4-1BB monoclonal antibody enhances rejection of large tumor burden by promoting survival but not clonal expansion of tumor-specific CD8+ T cells
Kenneth F May, Lieping Chen, Pan Zheng, et al.
Angewandte Chemie (International Ed. in English)
|
June 10, 2022
Biodegradable Ca<sup>2+</sup> Nanomodulators Activate Pyroptosis through Mitochondrial Ca<sup>2+</sup> Overload for Cancer Immunotherapy
Pan Zheng, Binbin Ding, Guoqing Zhu, et al.
Journal of Cutaneous Pathology
|
July 29, 2006
Cutaneous marginal zone B-cell lymphoma in the setting of fluoxetine therapy: a hypothesis regarding pathogenesis based on in vitro suppression of T-cell-proliferative response
Thomas S Breza, Pan Zheng, Pierluigi Porcu, et al.
Plos One
|
April 4, 2019
Prediction of Sphingosine protein-coding regions with a self adaptive spectral rotation method
Zhongwei Li, Yanan Guan, Xiang Yuan, et al.
Cancer Research
|
July 9, 2009
Activating transcription factor 2 and c-Jun-mediated induction of FoxP3 for experimental therapy of mammary tumor in the mouse
Yan Liu, Yin Wang, Weiquan Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 4, 2009
B7 blockade alters the balance between regulatory T cells and tumor-reactive T cells for immunotherapy of cancer
Penghui Zhou, Xincheng Zheng, Huiming Zhang, et al.
Page
of 29
Search research articles
Search
Showing results (41-50 of 281) with videos related to
Sort By:
Page
of 29
Molecules (Basel, Switzerland)
|
May 31, 2018
Small Universal Bacteria and Plasmid Computing Systems
Xun Wang, Pan Zheng, Tongmao Ma, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 25, 2025
Drug Development
Peng Wang, Ido Weiss, Pan Zheng, et al.
Plos One
|
October 27, 2010
Transgenic expression of P1A induced thymic tumor: a role for onco-fetal antigens in tumorigenesis
Chi-Shan Li, Chong Chen, Pan Zheng, et al.
Science (New York, N.Y.)
|
March 7, 2009
CD24 and Siglec-10 selectively repress tissue damage-induced immune responses
Guo-Yun Chen, Jie Tang, Pan Zheng, et al.
Cancer Research
|
June 18, 2002
Anti-4-1BB monoclonal antibody enhances rejection of large tumor burden by promoting survival but not clonal expansion of tumor-specific CD8+ T cells
Kenneth F May, Lieping Chen, Pan Zheng, et al.
Angewandte Chemie (International Ed. in English)
|
June 10, 2022
Biodegradable Ca<sup>2+</sup> Nanomodulators Activate Pyroptosis through Mitochondrial Ca<sup>2+</sup> Overload for Cancer Immunotherapy
Pan Zheng, Binbin Ding, Guoqing Zhu, et al.
Journal of Cutaneous Pathology
|
July 29, 2006
Cutaneous marginal zone B-cell lymphoma in the setting of fluoxetine therapy: a hypothesis regarding pathogenesis based on in vitro suppression of T-cell-proliferative response
Thomas S Breza, Pan Zheng, Pierluigi Porcu, et al.
Plos One
|
April 4, 2019
Prediction of Sphingosine protein-coding regions with a self adaptive spectral rotation method
Zhongwei Li, Yanan Guan, Xiang Yuan, et al.
Cancer Research
|
July 9, 2009
Activating transcription factor 2 and c-Jun-mediated induction of FoxP3 for experimental therapy of mammary tumor in the mouse
Yan Liu, Yin Wang, Weiquan Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 4, 2009
B7 blockade alters the balance between regulatory T cells and tumor-reactive T cells for immunotherapy of cancer
Penghui Zhou, Xincheng Zheng, Huiming Zhang, et al.
Page
of 29